Table 3.

The mean (± standard deviation) foveal thickness (μm) at various points after the first injection in each treatment schedule group

Treatment schedule
During the third year	Baseline	1 year	2 years	3 years
All eyes (n = 128)	338 (127)	206 (69)	212 (62)	212 (55)
As-needed injections determined by quarterly examination schedule
(n = 28)	349 (154)	206 (60)	190 (39)	216 (41)
As-needed injections determined by monthly examination schedule
(n = 61)	303 (120)	201 (73)	200 (65)	198 (53)
Monthly injection schedule (n = 18)	380 (122)	214 (72)	255 (49)	231 (48)
Treat-and-extend schedule (n = 21)	377 (73)	213 (70)	239 (68)	225 (73)